Clinical Profile and Outcomes of Shock in Children Aged 5-15 Years at a Tertiary Care Hospital

Sanjay Chavan1, Sarnya Verma, Manoj Patil

  • 1Department of Pediatrics, Dr. D. Y. Patil Medical College, Hospital and Research Center, Pune, Maharashtra, India.

Insights

Pediatric shock in school-aged children is often septic shock, with high mortality linked to neurological issues and multiple inotropes. Early recognition and treatment are key for survival in pediatric shock patients.

Area of Science:

  • Pediatric Critical Care Medicine
  • Pediatric Infectious Diseases
  • Pediatric Cardiology

Background:

  • Pediatric shock in school-aged children presents unique challenges differing from younger age groups.
  • Understanding age-specific shock characteristics is vital for effective management and improved outcomes.

Purpose of the Study:

  • To investigate the clinico-etiological profile of shock in children aged 5-15 years.
  • To analyze laboratory correlations and clinical outcomes in pediatric shock patients.
  • To evaluate management strategies and survival rates in school-aged children with shock.

Main Methods:

  • A prospective observational study involving 49 children aged 5-15 years over 24 months.
  • Shock identification based on tachycardia/hypotension with hypoperfusion signs.
  • Classification included septic, cardiogenic, and distributive shock, with laboratory and SOFA scoring.

Main Results:

  • Septic shock was most prevalent (63.3%), followed by cardiogenic (20.4%) and distributive (16.3%).
  • Elevated inflammatory markers and lactate were observed; respiratory and CNS infections were common causes of septic shock.
  • Mortality was 18.4%, associated with multiple inotropes and altered sensorium; higher SOFA scores correlated with longer ICU stays.

Conclusions:

  • Septic shock is common in school-aged children with significant mortality.
  • Neurological involvement and need for multiple inotropes predict poor outcomes in pediatric shock.
  • Early recognition, prompt antimicrobial therapy, and hemodynamic support are critical for improving survival.
Abstract

Related Concept Videos

Blood Pressure Imbalances and Circulatory Shock01:24

Blood Pressure Imbalances and Circulatory Shock

Disorders affecting blood volume, vascular tone, or vascular function can disrupt vascular homeostasis, including conditions like hypertension, hemorrhage, and shock.
Blood Pressure: Hypertension and Hypotension
Normal blood pressure is 120/80 mm Hg. Elevated blood pressure is 120-129/under 80 mm Hg. Hypertension, warranting treatment at 130/80 mm Hg, is often asymptomatic and can lead to severe cardiovascular events, aneurysms, peripheral arterial disease, chronic renal disease, or cardiac...
1.9K
Drug Dosing: Infants and Children01:29

Drug Dosing: Infants and Children

Pediatric patient dosages diverge from adults due to disparities in body surface area, total body water, and extracellular fluid per kilogram of body weight. The dosing regimen considers the variations in pharmacokinetics and pharmacology across distinct age groups, encompassing preterm newborns, infants, young children, older children, and adolescents. Calculation of pediatric patient doses is predicated on determining body surface area, which exhibits a superior correlation with the child's...
859
Pharmacokinetics in Pediatric Patients: Drug Distribution01:17

Pharmacokinetics in Pediatric Patients: Drug Distribution

Drug distribution in the pediatric population exhibits unique challenges and considerations due to the physiological differences between children, particularly neonates and infants, and adults. A crucial aspect of pediatric pharmacology is understanding how these differences impact the pharmacokinetics of various drugs, necessitating age-specific dosing strategies to ensure efficacy and safety.Neonates and infants have a higher total body water content, ~75%–90% of their body weight,...
496
Pharmacokinetics in Pediatric Patients: Overview and Drug Absorption01:23

Pharmacokinetics in Pediatric Patients: Overview and Drug Absorption

Understanding the physiological differences in the pediatric population is crucial for effective pharmacotherapy. Neonates, infants, and children exhibit significant variations in gastric pH, gastric emptying time, intestinal transit time, and biliary function. These variations profoundly affect oral drug absorption, necessitating a nuanced approach to pediatric dosing.Neonates present with a unique physiological profile, having a gastric pH greater than 4 and faster and more irregular gastric...
811
Pharmacokinetics in Pediatric Patients: Drug Excretion01:26

Pharmacokinetics in Pediatric Patients: Drug Excretion

In pediatric medicine, understanding the renal function and drug elimination nuances is crucial for administering safe and effective treatments. Newborns, in particular, display markedly slower renal functions than adults, profoundly affecting how drugs are cleared from their bodies. This slower drug clearance requires clinicians to extend the dosing intervals for many medications to prevent drug accumulation and toxicity while ensuring therapeutic efficacy.One key area where these adjustments...
388
Cardiopulmonary Resuscitation IV: Pharmacological Management01:25

Cardiopulmonary Resuscitation IV: Pharmacological Management

Pharmacologic intervention is crucial in treating cardiac arrest patients during ACLS or Advanced Cardiovascular Life Support. The ACLS algorithms guide the administration of specific drugs based on the patient's cardiac arrest rhythm, which includes pulseless ventricular tachycardia (VT), ventricular fibrillation (VF), asystole, and pulseless electrical activity (PEA).EpinephrineIndication: Epinephrine is the first-line drug for all cardiac arrest rhythms.Mechanism of Action: Epinephrine...
1.4K